Last update 23 Jan 2025

Galapagos SA

Holding Company|
1994|
Luxembourg

Overview

Tags

Other Diseases
Immune System Diseases
Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases3
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug6
Top 5 TargetCount
TYK2(Tyrosine-protein kinase 2)1
SIK1 x SIK2 x SIK31
SIK2 x SIK31
SIK1(salt inducible kinase 1)1
PAK1 x SIK11

Related

6
Drugs associated with Galapagos SA
GLPG-3667
Target
TYK2
Mechanism
TYK2 inhibitors
Active Org.
Galapagos NVGalapagos NV [+1]
Originator Org.
Galapagos NVGalapagos NV
Active Indication
Systemic Lupus Erythematosus [+1]
Inactive Indication
Plaque psoriasis
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
HG-99101
Target
QIK subfamily
Mechanism
QIK subfamily inhibitors
Active Org.
University Of DundeeUniversity Of Dundee [+1]
Originator Org.
Galapagos SA
Active Indication
Autoimmune Diseases [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
JRD-SIK1/2i-4
Target
SIK2 x SIK3
Mechanism
SIK2 inhibitors [+1]
Active Org.
Galapagos SA
Originator Org.
Galapagos SA
Active Indication
Autoimmune Diseases [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Galapagos SA
Login to view more data
0 Patents (Medical) associated with Galapagos SA
Login to view more data
100 Deals associated with Galapagos SA
Login to view more data
100 Translational Medicine associated with Galapagos SA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
4
2
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
GLPG-3667
 ( TYK2 )		Systemic Lupus Erythematosus
More
Preclinical
JRD-SIK1/2i-4
 ( SIK2 x SIK3 )		Inflammation
More
Preclinical
MRIA-9
 ( PAK1 x SIK1 )		Inflammation
More
Discovery
SK-124
 ( SIK1 x SIK2 x SIK3 )		Inflammation
More
Discovery
YKL-05099
 ( SIK1 )		Inflammation
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free